A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- Why Are People With Red Hair More Prone To Skin Cancer?on September 18, 2022 at 9:50 am
Redheads have been reported to be at increased risk of developing skin cancer, but why is this the case? What is it about red hair that makes people at risk?
- Studies Will Investigate Novel Drug in Colon and Skin Canceron September 16, 2022 at 6:00 am
Botensilimab will be evaluated in certain patients with colorectal cancer and melanoma, a type of skin cancer, in two recently launched clinical trials.
- New Treatment Approach Boosts Odds Against 2 Types of Skin Canceron September 15, 2022 at 7:52 am
Skin cancer patients appear to fare better if they receive immunotherapy before their cancers are surgically removed, a pair of clinical trials show.
- Addressing Skin Cancer in People of Colouron September 15, 2022 at 5:42 am
Skin cancer in people of colour requires more attention according to a new study presented at the Skin of Color Update meeting.
- MD Anderson: Many skin cancer tumors disappear with new therapyon September 12, 2022 at 7:57 am
More than six in 10 patients with an advanced stage of a common type of skin cancer saw their tumors nearly or completely disappear when treated with immunotherapy before surgery, MD Anderson ...
- Skin cancer around the eye; What you need to know about warning signs, treatmenton September 7, 2022 at 10:16 pm
Skin cancer is the most common type of cancer in the United States. According to MD Anderson, about 20% of people in the U.S. will have skin cancer at least once by age 70. In Texas, the rate of skin ...
- Is skin cancer itchy?on August 30, 2022 at 3:29 am
AROUND 147,000 new cases of non-melanoma skin cancer are diagnosed every year in the UK, according to the NHS Knowing the symptoms and what to look out for could save you or a loved one's life.
- Young father diagnosed with skin cancer reveals six signs you should see a GPon August 26, 2022 at 4:09 am
Shane McCormick, 47, who now works as a landscaping sector manager, was initially diagnosed with skin cancer in 2017 after a mole was removed, but thought he was in the clear until, two years ...
- Skin cancer: What are the signs and symptoms – and what does it look like?on August 25, 2022 at 1:59 am
YOU might think that you can only get skin cancer if you're a so-called 'sun worshipper' but experts say that is simply not the case. It's a condition that is becoming increasingly common in the ...
- Skin cancer signs and symptoms: From melanoma to carcinomaon August 22, 2022 at 6:46 am
With skin cancer rates soaring in recent years, now expected to climb even further, it's important to know the signs and symptoms of the condition. Rates of melanoma alone have increased by around ...
via Bing News